ClinConnect ClinConnect Logo
Search / Trial NCT05944705

Commercially Available Cannabis Products for Immune Support

Launched by CENTER FOR INTERVENTIONAL PAIN AND SPINE · Jul 6, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how commercially available hemp and cannabis products might help support the immune system in people with illnesses like influenza, COVID-19, or the common cold. The study is currently recruiting participants aged 18 and older who are part of the Pennsylvania medical marijuana program. To join, individuals must be experiencing symptoms such as fever, cough, fatigue, or sore throat, and they need to agree to use a specific hemp or cannabis product throughout the study.

Participants will fill out questionnaires and stay in touch through a smartphone or email, helping researchers understand the effects of these products on their symptoms. However, some people can't join, like those who are pregnant, have certain allergies, or are seriously ill. It's a great opportunity for those who qualify to contribute to understanding how these products might aid in immune support during common illnesses.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. 18 years of age or older
  • 2. Able to read and write in English
  • 3. Active participants in the Pennsylvania medical marijuana program (for cannabis product users)
  • 4. Currently experiencing one or more of the following symptoms due to an acute illness:
  • 1. Fever or chills
  • 2. Cough
  • 3. Fatigue
  • 4. Muscle or body aches
  • 5. Headache
  • 6. Sore throat
  • 7. Congestion or runny nose
  • 8. Nausea or Vomiting
  • 9. Diarrhea
  • 5. Agrees to consume their chosen hemp or cannabis product (for the cannabis arm) and to not use a different hemp or cannabis product through the duration of the study
  • 6. Agrees to continue to abstain from using hemp or cannabis (for the non-cannabis/hemp using arm)
  • 7. Must have smart phone or email and access to the internet
  • 8. Be able to comply with study requirements including baseline, completion of electronic questionnaires, and study timeline parameters.
  • Exclusion Criteria:
  • 1. Women who are pregnant, breastfeeding, or planning to become pregnant.
  • 2. Known allergy to any compounds in hemp or cannabis.
  • 3. Endorses suicidal intent
  • 4. Immunocompromised individuals
  • 5. Unwilling or unable to comply with study procedures
  • 6. Terminal Illness with life expectancy less than 1 year

About Center For Interventional Pain And Spine

The Center for Interventional Pain and Spine is a leading clinical research organization dedicated to advancing the field of pain management through innovative interventional techniques. With a focus on improving patient outcomes, the center conducts rigorous clinical trials that explore cutting-edge therapies and interventions for various pain conditions. Committed to ethical standards and patient safety, the organization collaborates with healthcare professionals and researchers to contribute to the evolving landscape of pain management, ensuring that the latest evidence-based practices are accessible to patients.

Locations

Bryn Mawr, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Philip Kim, MD

Principal Investigator

Center For Interventional Pain and Spine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported